Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Medical Oncology
•
Immune-related adverse events
•
Neurology
•
Neuromuscular
How do you manage immunotherapy-induced myasthenia gravis?
Answer from: at Academic Institution
My go-to algorithm is well-represented in the paper by Dr. @Adeel Zubair et al. Zubair et al., PMID 36439604
Sign in or Register to read more
Answer from: Medical Oncologist at Community Practice
NCCN "Management of Immunotherapy-Related Toxicities" has a useful 'cheat sheet' as a quick reference for the overnight call.
Sign in or Register to read more
19074
19390
Related Questions
How do you dose gabapentin in patients with renal failure?
Do you find IVIG to be an effective maintenance therapy for myasthenia gravis?
How do different inflammatory markers like CRP and ferritin contribute differently, if at all, to the monitoring of CART neurotoxicity?
When is the best time to try targeted therapy in adult-type diffuse non-IDH glioma?
How do you workup patients with neuropathy suspected to be secondary to sarcoid?
What recommendations would you make for a patient on long-term phenytoin due to epilepsy with a newly diagnosed breast cancer requiring doxorubicin as part of her chemotherapy?
What is your approach to a child with toe walking with a reassuring exam but a family history of difficulty walking?
How do you treat benign fasciculation syndrome?
How would one approach treating a patient with primary immunodeficiency on IVIG treatment who develops myasthenia gravis?
How do you counsel patients with ALS on the benefits of enteral nutrition?